ENTRY       D09888                      Drug
NAME        Drozitumab (USAN/INN)
FORMULA     C6334H9792N1700O2000S42
EXACT_MASS  143014.5047
MOL_WEIGHT  143102.4423
SEQUENCE    (Heavy chain)
            EVQLVQSGGG VERPGGSLRL SCAASGFTFD DYAMSWVRQA PGKGLEWVSG INWQGGSTGY
            ADSVKGRVTI SRDNAKNSLY LQMNSLRAED TAVYYCAKIL GAGRGWYFDY WGKGTTVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
            EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K
            (Light chain)
            SELTQDPAVS VALGQTVRIT CSGDSLRSYY ASWYQQKPGQ APVLVIYGAN NRPSGIPDRF
            SGSSSGNTAS LTITGAQAED EADYYCNSAD SSGNHVVFGG GTKLTVLGQP KAAPSVTLFP
            PSSEELQANK ATLVCLISDF YPGAVTVAWK ADSSPVKAGV ETTTPSKQSN NKYAASSYLS
            LTPEQWKSHK SYSCQVTHEG STVEKTVAPT ECS
            (Disulfide bridge: H22-H96, H148-H204, H265-H325, H371-H429, H230-H'230, H233-H'233, L21-L86, L135-L194, H224-L212)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-TRAIL receptor 2 antibody
  TYPE      Monoclonal antibody
TARGET      TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
  PATHWAY   hsa04060(8795)  Cytokine-cytokine receptor interaction
            hsa04115(8795)  p53 signaling pathway
            hsa04210(8795)  Apoptosis
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF10B (TRAILR2, CD262)
                 D09888  Drozitumab (USAN/INN)
DBLINKS     CAS: 912628-39-8
            PubChem: 124490605
///
